{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T12:28:38Z","timestamp":1769084918901,"version":"3.49.0"},"reference-count":25,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T00:00:00Z","timestamp":1766188800000},"content-version":"vor","delay-in-days":1848,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2020,11,28]],"date-time":"2020-11-28T00:00:00Z","timestamp":1606521600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Momentum Inc. USa"},{"name":"Momentum Research Inc."}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>The relationship between N-terminal pro-brain natriuretic peptide (NT-pro-BNP) and galectin-3 and outcomes has not been studied in African patients with acute heart failure (AHF). The current analysis sought to describe the association between plasma levels of NT-pro-BNP and galectin-3 and cardiovascular (CV) death or heart failure (HF) hospitalization, as well as their associations with symptoms and echocardiography markers of left and right ventricular remodelling among AHF patientsv in sub-Saharan Africa.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>In a subset of 80 patients with complete data in a study assessing the effects of hydralazine and nitrates in patients with AHF (BAHEF trial; NCT01822808), NT-pro-BNP and galectin-3 analyses were performed, and the association with various characteristics and outcome measures assessed. The mean age of the patients for whom the aforementioned biomarkers were measured was 52.6 years, with 52.5% women. Galectin-3 at baseline predicted changes (Week 24 to baseline) in left ventricular ejection fraction, left ventricular end-systolic diameter, left ventricular end-diastolic diameter, and tricuspid annular plane systolic excursion. Biomarkers and their changes were not associated with changes in 6 min walk test at 24 weeks. Baseline galectin-3 and change in NT-pro-BNP were associated with improvements in dyspnoea at 24 weeks. Nine patients had an HF readmission or died of CV causes through 24 weeks (11.6%). Both biomarkers at baseline predicted combined CV death or HF hospitalization through Week 24 (P-values = 0.0328 and 0.0001, respectively).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In a cohort of patients with AHF from sub-Saharan Africa, NT-pro-BNP and galectin-3 at baseline and their changes were associated with some changes in dyspnoea, echocardiographic remodelling, and CV death or HF hospitalization through Week 24. These tests have potential of being used for risk stratification of AHF patients in sub-Saharan Africa where resources are scarce.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/ehf2.13032","type":"journal-article","created":{"date-parts":[[2020,11,28]],"date-time":"2020-11-28T07:50:40Z","timestamp":1606549840000},"page":"74-84","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["N-Terminal pro BNP and Galectin-3 are Prognostic Biomarkers of Acute Heart Failure in Sub-Saharan Africa: Lessons from the BAHEF Trial"],"prefix":"10.1093","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8946-129X","authenticated-orcid":false,"given":"Mahmoud U.","family":"Sani","sequence":"first","affiliation":[{"name":"Department of Medicine, Bayero University Kano\/Aminu Kano Teaching Hospital , Kano ,","place":["Nigeria"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albertino","family":"Damasceno","sequence":"additional","affiliation":[{"name":"Eduardo Mondlane University , Maputo ,","place":["Mozambique"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beth A.","family":"Davison","sequence":"additional","affiliation":[{"name":"Momentum Research Inc. , Durham, NC ,","place":["USA"]},{"name":"Inserm 942 MASCOT , Paris ,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gad","family":"Cotter","sequence":"additional","affiliation":[{"name":"Momentum Research Inc. , Durham, NC ,","place":["USA"]},{"name":"Inserm 942 MASCOT , Paris ,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bongani M.","family":"Mayosi","sequence":"additional","affiliation":[{"name":"Department of Medicine, Groote Schuur Hospital and University of Cape Town , Cape Town ,","place":["South Africa"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Edwards","sequence":"additional","affiliation":[{"name":"Momentum Research Inc. , Durham, NC ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feriel","family":"Azibani","sequence":"additional","affiliation":[{"name":"Hatter Institute for Cardiovascular Research in Africa & IDM, Inter Cape Heart Group South African Medical Research Council, Department of Medicine, Faculty of Health Sciences, University of Cape Town , Cape Town ,","place":["South Africa"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tasneem","family":"Adam","sequence":"additional","affiliation":[{"name":"Hatter Institute for Cardiovascular Research in Africa & IDM, Inter Cape Heart Group South African Medical Research Council, Department of Medicine, Faculty of Health Sciences, University of Cape Town , Cape Town ,","place":["South Africa"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gulnaze","family":"Arif","sequence":"additional","affiliation":[{"name":"Eduardo Mondlane University , Maputo ,","place":["Mozambique"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neusa","family":"Jessen","sequence":"additional","affiliation":[{"name":"Eduardo Mondlane University , Maputo ,","place":["Mozambique"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Sliwa","sequence":"additional","affiliation":[{"name":"Hatter Institute for Cardiovascular Research in Africa & IDM, Inter Cape Heart Group South African Medical Research Council, Department of Medicine, Faculty of Health Sciences, University of Cape Town , Cape Town ,","place":["South Africa"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2020,11,28]]},"reference":[{"key":"2026012114034238500_ehf213032-bib-0001","doi-asserted-by":"crossref","first-page":"S129","DOI":"10.1097\/01.CCM.0000296274.51933.4C","article-title":"Practical recommendations for prehospital and early in-hospital management of patients presenting with acute heart failure syndromes","volume":"36","author":"Mebazaa","year":"2008","journal-title":"Crit Care Med"},{"key":"2026012114034238500_ehf213032-bib-0002","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1161\/CIRCULATIONAHA.108.786244","article-title":"Predominance of heart failure in the Heart of Soweto Study cohort: emerging challenges for urban African communities","volume":"118","author":"Stewart","year":"2008","journal-title":"Circulation"},{"key":"2026012114034238500_ehf213032-bib-0003","first-page":"835","article-title":"A predominance of hypertensive heart failure in the Abuja Heart Study cohort of urban Nigerians: a prospective clinical registry of 1515 de novo cases","volume":"15","author":"Ojji","year":"2013","journal-title":"EurJHeart Fail"},{"key":"2026012114034238500_ehf213032-bib-0004","first-page":"410","volume-title":"Heart Failure: A Companion to Braunwald's Heart Disease","author":"Sliwa","year":"2016"},{"key":"2026012114034238500_ehf213032-bib-0005","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1161\/01.CIR.0000144310.04433.BE","article-title":"N-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients","volume":"110","author":"Bettencourt","year":"2004","journal-title":"Circulation"},{"key":"2026012114034238500_ehf213032-bib-0006","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1056\/NEJMoa020233","article-title":"Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure","volume":"347","author":"Maisel","year":"2002","journal-title":"N Engl J Med"},{"key":"2026012114034238500_ehf213032-bib-0007","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.amjcard.2004.12.032","article-title":"The N-terminal Pro-BNP Investigation of Dyspnea in the Emergency department (PRIDE) study","volume":"95","author":"Januzzi","year":"2005","journal-title":"Am J Cardiol"},{"key":"2026012114034238500_ehf213032-bib-0008","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1067\/mem.2002.121483","article-title":"B-type natriuretic peptide predicts future cardiac events in patients presenting to the emergency department with dyspnea","volume":"39","author":"Harrison","year":"2002","journal-title":"Ann Emerg Med"},{"key":"2026012114034238500_ehf213032-bib-0009","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1751-7133.2008.08214.x","article-title":"Inpatient monitoring and prognostic importance of B-type natriuretic peptide","volume":"14","author":"Aspromonte","year":"2008","journal-title":"Congest Heart Fail"},{"key":"2026012114034238500_ehf213032-bib-0010","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1161\/01.CIR.0000147181.65298.4D","article-title":"Galectin-3 marks activated macrophages in failure-prone hypertrophied hearts and contributes to cardiac dysfunction","volume":"110","author":"Sharma","year":"2004","journal-title":"Circulation"},{"key":"2026012114034238500_ehf213032-bib-0011","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3109\/07853890.2010.538080","article-title":"Predictive value of plasma galectin-3 levels in heart failure with reduced and preserved ejection fraction","volume":"43","author":"deBoer","year":"2011","journal-title":"Ann Med"},{"key":"2026012114034238500_ehf213032-bib-0012","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.acvd.2013.06.054","article-title":"Galectin-3: a new biomarker for the diagnosis, analysis and prognosis of acute and chronic heart failure","volume":"106","author":"Hrynchyshyn","year":"2013","journal-title":"Arch Cardiovasc Dis"},{"key":"2026012114034238500_ehf213032-bib-0013","doi-asserted-by":"crossref","first-page":"706","DOI":"10.3109\/1354750X.2012.719037","article-title":"Galectin 3 complements BNP in risk stratification in acute heart failure","volume":"17","author":"Fermann","year":"2012","journal-title":"Biomarkers"},{"key":"2026012114034238500_ehf213032-bib-0014","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.jacc.2006.03.061","article-title":"Utility of amino-terminal pro-brain natriuretic peptide, galectin-3, and apelin for the evaluation of patients with acute heart failure","volume":"48","author":"vanKimmenade","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"2026012114034238500_ehf213032-bib-0015","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1093\/eurjhf\/hfq091","article-title":"Galectin-3, cardiac structure and function, and long-term mortality in patients with acutely decompensated heart failure","volume":"12","author":"Shah","year":"2010","journal-title":"Eur J Heart Fail"},{"key":"2026012114034238500_ehf213032-bib-0016","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s00392-010-0125-y","article-title":"Prognostic value of galectin-3, a novel marker of fibrosis, in patients with chronic heart failure: data from the DEAL-HF study","volume":"99","author":"Lok","year":"2010","journal-title":"Clin Res Cardiol"},{"key":"2026012114034238500_ehf213032-bib-0017","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.jacc.2012.04.053","article-title":"Galectin-3, a marker of cardiac fibrosis, predicts incident heart failure in the community","volume":"60","author":"Ho","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"2026012114034238500_ehf213032-bib-0018","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1002\/ejhf.581","article-title":"Bi treatment with hydralazine\/nitrates vs. placebo in Africans admitted with acute HEart Failure (BA-HEF)","volume":"18","author":"Sliwa","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"2026012114034238500_ehf213032-bib-0019","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ahj.2004.08.005","article-title":"Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE)","volume":"149","author":"Adams","year":"2005","journal-title":"Am Heart J"},{"key":"2026012114034238500_ehf213032-bib-0020","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1001\/archinternmed.2012.3310","article-title":"The causes, treatment, and outcome of acute heart failure in 1006 Africans from 9 countries","volume":"172","author":"Damasceno","year":"2012","journal-title":"Arch Intern Med"},{"key":"2026012114034238500_ehf213032-bib-0021","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1056\/NEJMoa042934","article-title":"Combination of isosorbide dinitrate and hydralazine in blacks with heart failure","volume":"351","author":"Taylor","year":"2004","journal-title":"N Engl J Med"},{"key":"2026012114034238500_ehf213032-bib-0022","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1016\/j.cardfail.2011.06.311","article-title":"Plasma galectin-3 is associated with near-term rehospitalization in heart failure: a meta-analysis","volume":"17","author":"deBoer","year":"2011","journal-title":"J Card Fail"},{"key":"2026012114034238500_ehf213032-bib-0023","doi-asserted-by":"crossref","first-page":"233","DOI":"10.5830\/CVJA-2014-050","article-title":"The proposed role of plasma NT pro-brain natriuretic peptide in assessing cardiac remodelling in hypertensive African subjects","volume":"25","author":"Ojji","year":"2014","journal-title":"Cardiovasc J Afr"},{"key":"2026012114034238500_ehf213032-bib-0024","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1136\/heart.83.3.278","article-title":"Influence of hypertension, left ventricular hypertrophy, and left ventricular systolic dysfunction on plasma N terminal proBNP","volume":"83","author":"Talwar","year":"2000","journal-title":"Heart"},{"key":"2026012114034238500_ehf213032-bib-0025","first-page":"35","article-title":"Cardiopulmonary laboratory biomarkers in the evaluation of acute dyspnea","volume":"8","author":"Stokes","year":"2016","journal-title":"Open Access Emerg Med"}],"container-title":["ESC Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ehf2.13032","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/ehf2.13032","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/8\/1\/74\/65798901\/eschf_8_1_74.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/8\/1\/74\/65798901\/eschf_8_1_74.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T19:03:59Z","timestamp":1769022239000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eschf\/article\/8\/1\/74\/8369286"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,28]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,11,28]]},"published-print":{"date-parts":[[2021,2,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ehf2.13032","relation":{},"ISSN":["2055-5822"],"issn-type":[{"value":"2055-5822","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,2]]},"published":{"date-parts":[[2020,11,28]]},"assertion":[{"value":"2020-05-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-09-10","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-11-28","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}